When shopping while black happens to me, I take my business elsewhere.
Not so long ago global cash seeking safety and liquidity was keeping the yield on the 10-year Treasury at 2.95% in spite of the huge budget deficit resulting from the December Tax Cuts & Jobs Act and the flood of bond sales by the U.S. Treasury and the prospect of more interest rate increases from the Fed. But now in the last two days 10-year Treasury yields have tacked on almost a full tenth of a percentage point and today the yield on the 10-year Treasury closed at 3.10%.
It hasn't exactly been a stellar couple of months for shares and options on Nektar Therapeutics (NKTR). The stock, which I hold in my Jubak Picks portfolio, is down 23.1% since it hit a high of $108.44 on March 8. The August 17, 2018 call options with a strike of $90 I bought on February 25, 2018 in my Volatility Portfolio are now down 39%. The stock looks like it may have stabilized at $77/$78 and it has edged higher to close at $83.40 today, May 15, after a gain of 3.05%, but the recent "progress" has been "limping" to anyone used to the gains this stock racked up in 2017. I think what you need to profit from Nektar shares or options now is some understanding of why the stock has struggled over the last two months. And, armed with that understanding, some patience as it takes longer than expected for positive catalysts to kick in.
Decent retail sales in April point to likely rebound in consumer spending from first quarter weakness
Not great numbers but strong enough. For April it looks like a strong job market and higher take-home pay more than balanced out higher gasoline prices. Gas prices are now at their highest level since 2014.